UCI Health urologists have tested a new laser technology capable of reducing even large kidney stones to dust that can be suctioned or flushed from the body. The super-pulsed thulium fiber laser is “a game-changer,” says Ralph V. Clayman, MD, distinguished professor of urology and dean emeritus of the UCI…
UC San Diego Health is conducting the first known randomized, double-blind, placebo-controlled clinical trial looking at cannabis as a potentially effective treatment for acute migraines.
By mapping its genetic underpinnings, researchers at University of California San Diego School of Medicine have identified a predictive causal role for specific cell types in type 1 diabetes, a condition that affects more than 1.6 million Americans.
The UC Davis Comprehensive Cancer Center is celebrating National Cancer Survivors Day in June with a virtual healing arts exhibit. The goal is to show how creative expression can help patients recover from cancer.
A UC Davis Health study urged gynecologic surgeons to prescribe the smallest effective opioid prescription after hysterectomy. Their study found that, on average, patients use only half of pills prescribed after the operation.
A study led by UC Davis toxicologist Pamela Lein found a link between traffic-related air pollution and an increased risk for age-related dementia, including Alzheimer's disease. More than 5 million Americans currently live with Alzheimer's disease.
A new multi-institution study led by a team of researchers at the David Geffen School of Medicine demonstrated that blocking a protein called ABCB10 in liver cells protects against high blood sugar and fatty liver disease in obese mice. Furthermore, ABCB10 activity prompted insulin resistance in human liver cells.
Race-based reference ranges will no longer be part of a test routinely used to check a patient’s kidney health. UC Davis Health is one of the first in the nation to make the change to the estimated glomerular filtration rate or eGFR.
Two researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received over $10 million in grants from the California Institute for Regenerative Medicine, the state’s stem cell agency, to develop cell therapies for melanoma and multiple myeloma.
Health Media Contacts
Find the best contact for health-related media inquiries.
